-
平臺編號：bio-68474
-
國際編號：CRL-1962
-
細胞信息： QM7 (Quail muscle clone 7)
-
規(guī)格：frozen
-
用途：ATCC原裝細胞
-
服務費用：
加載中…… - 訂購
-
注意事項：僅用于科學研究或者工業(yè)應用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準）
QM7 (Quail muscle clone 7)
數(shù)量：大量
生長狀態(tài)：貼壁生長
ATCC Number：CRL-1962?
相關疾病：纖維肉瘤
年限：1 to 3 weeks
細胞形態(tài)：成纖維樣
運輸方式：凍存運輸
細胞類型：其他細胞類型
是否是腫瘤細胞：0
物種來源：其他
組織來源：muscle
規(guī)格：1mg Designations: QM7 (Quail muscle clone 7)
Depositors: ?PB Antin
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Coturnix coturnix japonica
Morphology:fibroblast
Source: Tissue: muscle
Disease: fibrosarcoma
Cell Type: myoblast myoblast; chemically induced
Cellular Products:desmin; cardiac troponin T; cardiac troponin C; skeletal troponin T; skeletal troponin I; alpha tropomyosin; muscle creatine kinase; myosin light chain 2; myosin heavy chain (ventricular form)
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: 1 to 3 weeks
Comments:The QM7 cell line was derived from the QT6 fibrosarcoma originally isolated by Moscovici, et al. from a tumor that developed in a bird treated with methylcholanthrene.
QM7 is a serum inducible myogenic cell line.
The cells replicate as myoblasts in medium containing serum.
When switched to medium without serum, the cells cease dividing and fuse to form large multinucleated myotubes.
In the myotube state, the cells express muscle specific proteins such as desmin, cardiac troponin T, cardiac troponin C, skeletal troponin T, skeletal troponin I, alpha tropomyosin.
Mucle creatine kinase, myosin light chain 2 and a ventricular form of myosin heavy chain.
They do not express any known form of alpha actin.
QM7 cells transfect with high efficiency, and are useful for studying many aspects of muscle differentiation and gene expression.
The myoblastic population will become depleted rapidly if the cultures are allowed to become confluent.
To prevent loss of myoblastic cell, cultures should be subcultured before they become confluent and the line should be recloned periodically with selection for myoblastic cells.
Propagation: ATCC complete growth medium: Medium 199 with Earle's BSS, 80%; tryptose phosphate broth, 10%; fetal bovine serum, 10%
Temperature: 37.0°C
Subculturing: Protocol: The myoblastic population will become depleted rapidly if the cultures are allowed to become confluent. Remove spent medium, add fresh 0.25% trypsin, 0.03% EDTA solution, rinse and remove trypsin solution. Incubate the flask at room temperature until the cells detach (about 5 minutes). Add fresh medium, aspirate and dispense into new flasks.
Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:5 is recommended
Medium Renewal: Every 2 to 3 days
References: 23002: Antin PB, Ordahl CP. Isolation and characterization of an avian myogenic cell line. Dev. Biol. 143: 111-121, 1991. PubMed: 1985013
70419: Rong S, Sheppard MG. Processes for preparation of Marek's disease virus using continuous avian cell lines. US Patent 6,410,297 dated Jun 25 2002
生長狀態(tài)：貼壁生長
ATCC Number：CRL-1962?
相關疾病：纖維肉瘤
年限：1 to 3 weeks
細胞形態(tài)：成纖維樣
運輸方式：凍存運輸
細胞類型：其他細胞類型
是否是腫瘤細胞：0
物種來源：其他
組織來源：muscle
規(guī)格：1mg Designations: QM7 (Quail muscle clone 7)
Depositors: ?PB Antin
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Coturnix coturnix japonica
Morphology:fibroblast
Source: Tissue: muscle
Disease: fibrosarcoma
Cell Type: myoblast myoblast; chemically induced
Cellular Products:desmin; cardiac troponin T; cardiac troponin C; skeletal troponin T; skeletal troponin I; alpha tropomyosin; muscle creatine kinase; myosin light chain 2; myosin heavy chain (ventricular form)
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: 1 to 3 weeks
Comments:The QM7 cell line was derived from the QT6 fibrosarcoma originally isolated by Moscovici, et al. from a tumor that developed in a bird treated with methylcholanthrene.
QM7 is a serum inducible myogenic cell line.
The cells replicate as myoblasts in medium containing serum.
When switched to medium without serum, the cells cease dividing and fuse to form large multinucleated myotubes.
In the myotube state, the cells express muscle specific proteins such as desmin, cardiac troponin T, cardiac troponin C, skeletal troponin T, skeletal troponin I, alpha tropomyosin.
Mucle creatine kinase, myosin light chain 2 and a ventricular form of myosin heavy chain.
They do not express any known form of alpha actin.
QM7 cells transfect with high efficiency, and are useful for studying many aspects of muscle differentiation and gene expression.
The myoblastic population will become depleted rapidly if the cultures are allowed to become confluent.
To prevent loss of myoblastic cell, cultures should be subcultured before they become confluent and the line should be recloned periodically with selection for myoblastic cells.
Propagation: ATCC complete growth medium: Medium 199 with Earle's BSS, 80%; tryptose phosphate broth, 10%; fetal bovine serum, 10%
Temperature: 37.0°C
Subculturing: Protocol: The myoblastic population will become depleted rapidly if the cultures are allowed to become confluent. Remove spent medium, add fresh 0.25% trypsin, 0.03% EDTA solution, rinse and remove trypsin solution. Incubate the flask at room temperature until the cells detach (about 5 minutes). Add fresh medium, aspirate and dispense into new flasks.
Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:5 is recommended
Medium Renewal: Every 2 to 3 days
References: 23002: Antin PB, Ordahl CP. Isolation and characterization of an avian myogenic cell line. Dev. Biol. 143: 111-121, 1991. PubMed: 1985013
70419: Rong S, Sheppard MG. Processes for preparation of Marek's disease virus using continuous avian cell lines. US Patent 6,410,297 dated Jun 25 2002
